Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 1,641 - 1,660 results of 5,491 for search 'significantly ((((lower decrease) OR (greater decrease))) OR (linear decrease))', query time: 0.42s Refine Results
  1. 1641
    Fig 2 -

    Fig 2 - by Masoud Rahmati (16665456)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1642
    Accuracy on the ERAM task.

    Accuracy on the ERAM task. by Daisung Jang (16781451)

    Published 2024
    “…However, coefficients for estrogen were significant for both emotion recognition tasks. Higher within-person levels of estrogen predicted lower accuracy, whereas higher between-person estrogen levels predicted greater accuracy. …”
    Save to List
    Saved in:
  3. 1643
    Fig 1 - Fusing multisensory signals across channels and time

    Fig 1 - Fusing multisensory signals across channels and time by Swathi Anil (17382903)

    Published 2025
    Save to List
    Saved in:
  4. 1644
    Data Sheet 1_Exploring the glucose-lowering and anti-inflammatory immune mechanism of artemether by AMPK/mTOR pathway and microbiome based on multi-omics.docx

    Data Sheet 1_Exploring the glucose-lowering and anti-inflammatory immune mechanism of artemether by AMPK/mTOR pathway and microbiome based on multi-omics.docx by Tao Jiang (28401)

    Published 2025
    Save to List
    Saved in:
  5. 1645
    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  6. 1646
    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  7. 1647
    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  8. 1648
    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  9. 1649
    Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  10. 1650
    Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  11. 1651
    Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  12. 1652
    Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  13. 1653
    Joint Efficiency (%) of ABS Polymers at 800 rpm and 1200 rpm.

    Joint Efficiency (%) of ABS Polymers at 800 rpm and 1200 rpm. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1654
    Schematic of fixture.

    Schematic of fixture. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1655
    Average shore hardness values of ABS and PC welded samples.

    Average shore hardness values of ABS and PC welded samples. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1656
    Fabricated Fixture with labelled view.

    Fabricated Fixture with labelled view. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1657
    Joint Efficiency (%) of PC Polymers at 800 rpm and 1200 rpm.

    Joint Efficiency (%) of PC Polymers at 800 rpm and 1200 rpm. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1658
    Tensile Strength (MPa) of PC Polymers at 800 rpm and 1200 rpm.

    Tensile Strength (MPa) of PC Polymers at 800 rpm and 1200 rpm. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1659
    Experimentation plan.

    Experimentation plan. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1660
    Experimental details.

    Experimental details. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: